Why Is CAREDX INC (CDNA) Stock Up Today?

Why CDNA stock is up today

CareDx Inc (CDNA) surged 14.02% to $43.44 in early trading on July 31, 2026, driven by a combination of a strong earnings report and a raised revenue outlook. The stock opened with a 7.6% gap up from the previous close and reached a session high of $43.79. The move followed the company’s second-quarter 2026 earnings report, which showed adjusted earnings per share of $0.37, beating estimates, and revenue of $131.948 million, also above forecasts. The company also raised its full-year 2026 revenue guidance to $490 million to $500 million from $447 million to $465 million.

What Happened

CareDx reported second-quarter 2026 results that exceeded expectations, with revenue rising 52% year-over-year to $132 million. The company also announced the start of its NavDx integration, a key strategic initiative expected to drive future growth. The updated guidance reflects stronger-than-anticipated performance and a more optimistic outlook for the remainder of the year. Additionally, the company filed a Form 8-K with the SEC disclosing the results and related financial details. H.C. Wainwright reiterates its Neutral rating on CareDx with a $46 price target, maintaining analyst coverage despite the recent stock move.

What The Data Shows

The stock’s intraday performance showed strong momentum, with volume reaching 0.7 million shares, or 0.8 times the 3-month average. The stock opened at $41.01 and traded as high as $43.79 within the first 15 minutes. Despite the sharp move, CareDx remains unprofitable with a trailing 12-month EPS of -0.16 and a net margin of -2.0%. The company’s market cap is $1.8 billion, and its revenue is growing at 19.2% TTM. The stock is currently trading near its 52-week high of $40.47. Over the past 90 days, insiders have sold 8 times totaling $8.2 million, with the most recent transaction on July 17.

What To Watch

The company’s next key event is the continued integration of NavDx, which is expected to provide further operational and financial updates in the coming quarters. Investors should also monitor coverage breadth and any follow-up analyst commentary as the stock continues to trade near its 52-week high.